18-hydroxycorticosterone has been researched along with Polycystic Ovary Syndrome in 1 studies
*Polycystic Ovary Syndrome: A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Chen, Y; Lin, T; Mao, L; Sang, Y; Wang, G; Zhu, B; Zhu, K; Zhu, Y | 1 |
1 other study(ies) available for 18-hydroxycorticosterone and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Serum steroid metabolome on the day of oocyte retrieval in women with polycystic ovarian syndrome and its association with pregnancy outcome of in vitro fertilization.
Topics: 17-alpha-Hydroxypregnenolone; 18-Hydroxycorticosterone; Chromatography, Liquid; Female; Fertilization in Vitro; Humans; Male; Oocyte Retrieval; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Retrospective Studies; Semen; Steroid 21-Hydroxylase; Tandem Mass Spectrometry | 2023 |